Stuttgart
20.01.26 | 15:01
0,012 Euro
+2.380 % +0,012
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,000 | 0,013 | 20.01. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.01. | Episurf has completed the first closing of the acquired real estate assets, convenes an extraordinary general meeting and announces a board change | 3 | Cision News | ||
| 08.01. | Notice of Extraordinary General Meeting of Episurf Medical AB (publ) | 1 | Cision News | ||
| 30.12.25 | Episurf Medical AB receives observation status | 181 | GlobeNewswire | Today, December 30, 2025, Episurf Medical AB (the "Company") issued a press release with information that the Company had entered into an agreement regarding the acquisition of all shares in Goldcup... ► Artikel lesen | |
| 30.12.25 | Episurf Medical AB: Episurf forms a new strategic business segment through the acquisition of real estate assets. The purchase price of SEK up to 1,147 million is partly paid through shares, convertibles and warrants | 154 | GlobeNewswire (Europe) | The Board of Directors of Episurf Medical AB (publ) (NASDAQ: EPIS B) ("Episurf" or the "Company") has today, 30 December 2025, entered into an agreement with Goldcup 38657 AB (under name change to Frusipe... ► Artikel lesen | |
| 18.11.25 | Update on Episurf Medical's MTP implant | 3 | Cision News | ||
| 02.11.25 | Board Member Resigns from the Board of Episurf Medical | 2 | Cision News | ||
| 24.10.25 | Episurf Medical AB: Interim Report 1 January - 30 September 2025 | 149 | GlobeNewswire (Europe) | Strong US growth in gross-order intake and customer base
Significantly improved financial results
Continued focus on regulatory pathway for MTP-implant
"This is my first CEO statement as CEO... ► Artikel lesen | |
| 17.10.25 | EPISURF MEDICAL AB: Scientific article on Episealer Knee with up to 10 years' follow-up published | 3 | Cision News | ||
| EPISURF MEDICAL Aktie jetzt für 0€ handeln | |||||
| 12.10.25 | Board Member Resigns from the Board of Episurf Medical | 3 | Cision News | ||
| 30.09.25 | Change in number of shares and votes in Episurf Medical | 2 | Cision News | ||
| 16.09.25 | Episurf Medical AB: New Chief Executive Officer at Episurf Medical | 347 | GlobeNewswire (Europe) | Episurf Medical (Nasdaq: EPIS B) today announces that, at his own request, Pål Ryfors will step down as Chief Executive Officer of Episurf Medical. The Board of Directors has appointed Katarina Flodström... ► Artikel lesen | |
| 01.09.25 | EPISURF MEDICAL AB: Episealer included in the Swedish Knee Arthroplasty Register 2025 | 4 | Cision News | ||
| 29.08.25 | Episurf Medical AB changes liquidity provider to Mangold Fondkommission AB | 2 | Cision News | ||
| 28.08.25 | Episurf Medical resolves on an issue of units to guarantors in connection with the completed rights issue | 1 | Cision News | ||
| 25.08.25 | Episurf Medical announces final outcome of the rights issue | 1 | Cision News | ||
| 22.08.25 | EPISURF MEDICAL AB: Preliminary outcome indicates significantly oversubscribed rights issue | 1 | Cision News | ||
| 20.08.25 | Episurf Medical announces interview with CEO | 1 | Cision News | ||
| 07.08.25 | Listing of units rights and paid subscription units of Episurf Medical AB | 339 | GlobeNewswire | With effect from August 08, 2025, the units rights of Episurf Medical AB will be traded on the list for Equity rights. Trading will continue up until and including August 19, 2025.
Instrument:
Units... ► Artikel lesen | |
| 05.08.25 | Episurf Medical publishes prospectus in connection with the company's rights issue of units | 2 | Cision News | ||
| 04.08.25 | Episurf Medical AB: Summary from the Extraordinary General Meeting of Episurf Medical AB (publ) | 250 | GlobeNewswire (Europe) | Episurf Medical AB (publ) held an Extraordinary General Meeting in Stockholm today 4 August 2025 at which it was resolved, among other things, to approve the Board of Directors' resolution on a rights... ► Artikel lesen |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IMUNON | 2,920 | -3,95 % | Imunon, Inc.: IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update | R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced... ► Artikel lesen | |
| ELECTROCORE | 5,800 | 0,00 % | electroCore, Inc.: electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8-$32.0 Million | Record revenue of approximately $31.8 - $32.0 million for full-year 2025 and approximately $9.0 - $9.2 million for the three months ended December 31, 2025 Revenue growth of approximately 26% over... ► Artikel lesen | |
| FRESENIUS | 47,120 | -4,56 % | DAX-Check LIVE: Commerzbank, Fresenius, Jost Werke, Nordex, Symrise, TKMS, Volkswagen Vz., Zalando | Der DAX ist mit weiteren Rekorden in die neue Woche gestartet und hat erstmals die Marke von 25.400 Punkten überschritten. Im Tageshoch erreichte der Leitindex 25.421 Punkte und markierte damit den... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 35,980 | -3,02 % | DAX-Check LIVE: Aixtron, BASF, Bayer, Fresenius Medical Care, K+S, SAP, Schaeffler im Fokus | Nach sieben Rekordtagen in Folge haben am Mittwoch am deutschen Aktienmarkt die Verkäufer die Oberhand gewonnen. Der DAX schloss 0,5 Prozent tiefer bei 25.286 Punkten. Nach sieben Rekordtagen in Folge... ► Artikel lesen | |
| INVO FERTILITY | 2,385 | 0,00 % | INVO Fertility, Inc.: INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026 | ||
| SIEMENS HEALTHINEERS | 44,520 | -0,29 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Siemens Healthineers auf "Outperform" mit einem Kursziel von 52,90 Euro belassen. 2025 sei ein schlechtes Jahr... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 35,460 | -5,49 % | Bechtle, Carl Zeiss Meditec, CTS Eventim, MTU Aero Engines, Suss MicroTec, TeamViewer - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| GENEDX | 99,47 | -7,97 % | Sema4.ai: Interview With Co-Founder & CEO Rob Bearden About The Enterprise AI Agent Platform | ||
| PROGYNY | 25,390 | +3,55 % | Forecasting The Future: 6 Analyst Projections For Progyny | ||
| HEARTFLOW | 34,190 | -7,99 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 38,730 | -1,20 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| BILLIONTOONE | 85,95 | -3,13 % | BillionToOne und Epic: Diagnostiktests werden in Patientenakten integriert | ||
| PROCEPT BIOROBOTICS | 30,300 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 22,730 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Appoints Adnan Mansour as Chief Digital Officer to Accelerate AI-Driven Growth and Technology Leadership | ||
| GERRESHEIMER | 25,180 | -2,10 % | BERNSTEIN RESEARCH stuft GERRESHEIMER AG auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Gerresheimer auf "Underperform" mit einem Kursziel von 25,68 Euro belassen. 2025 sei ein schlechtes Jahr für... ► Artikel lesen |
EPISURF MEDICAL AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,012 (+2.380 %) liegt der Kurs bei 0,012 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EPISURF MEDICAL AB finden Sie auf Wallstreet Online.